What is Zetia?
Zetia is an effective cholesterol-reducing medicine that prevents cholesterol absorption in the intestines. Moreover, it lowers the quantity of cholesterol stored in the liver and helps the body process cholesterol.
Zetia is an effective cholesterol-reducing medicine that prevents cholesterol absorption in the intestines. Moreover, it lowers the quantity of cholesterol stored in the liver and helps the body process cholesterol.
What is Vytorin? Vytorin is a well-known combination and
cholesterol-reducing medicine. The simvastatin protects your body from
producing bad cholesterol, (LDL) while increasing the good cholesterol (HDL).
Ezetimibe helps in preventing cholesterol absorption in the intestines while
reducing other risk problems.
Data
Suggests the drugs have limited benefits
According to some studies, both Zetia and Vytorin have
limited benefits. Information from a clinical trial demonstrates that the
cholesterol drugs don't produce any health advantages to users when contrasted
with high doses of bland Zocor, and they be made susceptible to risk of heart
attack and liver problems.
An article in the New York Times raised concern that
Zetia and Vytorin
reactions may increase the risk of liver damage when used in combination with
statin cholesterol drugs. Concerns about liver damage from Zetia
were raised after a spokesman for the medication producers recognized that a
few patients were expelled from the Enhance study in the wake of test results
showing that they had elevated liver proteins.
Zetia and Vytorin are prevalent medications prescribed
for treatment of high cholesterol. Around one million individuals receive one
of the medications every week. Zetia, which is produced by Merck and Co. also,
Schering-Plow Corp., works by obstructing the ingestion of cholesterol in the
digestive tract. Vytorin is a combination drug made by the same organizations,
which contains both Zetia and Zocor.
The study, known as Enhance, found that Zetia and Vytorin
symptoms brought on fatty plaques about twice as quick when contrasted to those
prescribed Zocor
alone. The clinical trial took around 720 people with elevated cholesterol for
prolonged periods. Clients of Vytorin and Zetia were observed to pass on or
endure heart entanglements as indicated by the information, however given the
nature of the trail, outcomes did not achieve the level of measurable
effectiveness. This implies the distinctions could have been brought on by
chance. Other studies are expected to better assess the risk.
Statins, which consist of Lipitor, Crestor and Zocor, are
regularly recommended with Zetia or as a component of the Vytorin pill, which
consolidates Zetia and Zocor. As indicated by the New York Times, there have
been a few reports of serious liver damage connected with the use of Zetia and
statins, and the combination has appeared to bring about liver damage as well.
The outcomes of the Enhance study were portrayed as
"shocking" by Dr. Steven Nissen, the director of cardiology at the
Cleveland Clinic, who wrote about the dangers of Avandia heart attack symptoms.
Dr. Nissen was one ofthe primary specialists to bring up issues with Vioxx,
which was reviewed in 2004.
Dr. Nisson recommended that Zetia and Vytorin should not
be prescribed unless all other cholesterol drugs have failed to work, as the
medication has no advantages and may open people to an expanded danger of heart
attacks. The FDA has not commented on the information yet. Speak with your doctor before changing any
medications. The legal advisors at
Saiontz & Kirk, P.A. are looking into data about the Zetia, and whether sufficient information has been gathered about the risks
and advantages of the medications. To learn more about Zetia and Vytorin,
please visit www.FindaTopDoc.com
today.
